In a second step, the impact of differences found regarding TLR1 expression between NAFLD patients and controls on disease development was assessed in a dietary mouse model employing TLR1−/− mice. The gene discussed is TLR1; the disease is metabolic dysfunction-associated steatotic liver disease.